<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="case-report" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">BMC Med Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">BMC Med. Genet</journal-id>
<journal-title-group>
<journal-title>BMC Medical Genetics</journal-title>
</journal-title-group>
<issn pub-type="epub">1471-2350</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32028929</article-id>
<article-id pub-id-type="pmc">7006404</article-id>
<article-id pub-id-type="publisher-id">954</article-id>
<article-id pub-id-type="doi">10.1186/s12881-020-0954-0</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A rare combination of MODY5 and duodenal atresia in a patient: a case report</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8863-7740</contrib-id>
<name>
<surname>Du</surname>
<given-names>Tao</given-names>
</name>
<address>
<email>dutao@gzhmu.edu.cn</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zeng</surname>
<given-names>Nan</given-names>
</name>
<address>
<email>1107783612@qq.com</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wen</surname>
<given-names>Xiaofang</given-names>
</name>
<address>
<email>1099218244@qq.com</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhu</surname>
<given-names>Peizhuang</given-names>
</name>
<address>
<email>gyeydu@163.com</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Li</surname>
<given-names>Wangen</given-names>
</name>
<address>
<email>liwg660@126.com</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<aff id="Aff1"><institution-wrap><institution-id institution-id-type="GRID">grid.412534.5</institution-id><institution>Department of Endocrinology, </institution><institution>The Second Affiliated Hospital of Guangzhou Medical University, </institution></institution-wrap>Guangzhou, 510260 People’s Republic of China </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>6</day>
<month>2</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>6</day>
<month>2</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<year>2020</year>
</pub-date>
<volume>21</volume>
<elocation-id>24</elocation-id>
<history>
<date date-type="received">
<day>4</day>
<month>7</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>15</day>
<month>1</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s). 2020</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<sec>
<title>Background</title>
<p id="Par1">Maturity-onset diabetes of the young (MODY) is a genetically and clinically heterogeneous group of hereditary diabetes, generally caused by one abnormal gene. MODY5 is caused by mutations of the hepatocyte nuclear factor 1 homeobox β gene (HNF1β), always as a part of Chr17q12 deletion, whereas heterozygous mutation in B lymphocyte kinase (BLK) gene is responsible for MODY11.</p>
</sec>
<sec>
<title>Case presentation</title>
<p id="Par2">We report a patient who developed diabetes with a 1.58-Mb Chr17q12 microdeletion and BLK gene c.211G &gt; A mutation using the cytoscan high-density array and whole-exome sequencing analysis. The patient received the surgery at five days after birth for the duodenal atresia and had normal growth postoperatively. Mild elevated liver enzymes were found along with the normal renal function. Quantitative analysis of β-cell function markers, including fasting insulin (&lt; 0.2 mIU/L), fasting C-peptide (0.02 μg/L), postprandial-2 h insulin (&lt; 0.2 mIU/L), and postprandial-2 h C-peptide (0.03 μg/L) suggested a severe loss of insulin secreting capacity. Meanwhile, islet autoantibodies (GADA, IA-2, ICA, and IAA) in the patient’s blood appeared negative. Neither dysplasia in other tissues nor abnormality in development and behavior was found.</p>
</sec>
<sec>
<title>Conclusion</title>
<p id="Par3">To date, gastrointestinal malformations were extremely rarely reported in patients with MODY. Our clinical report further expands the clinical presentation and variability of MODY5.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>17q12 microdeletion</kwd>
<kwd>Duodenal atresia</kwd>
<kwd>Hepatocyte nuclear factor beta</kwd>
<kwd>B lymphocyte kinase</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003453</institution-id>
<institution>Natural Science Foundation of Guangdong Province</institution>
</institution-wrap>
</funding-source>
<award-id>Natural Science Foundation of Guangdong Province of China</award-id>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>Science and Technology Planning Project of Guangzhou</institution>
</funding-source>
<award-id>201607010036</award-id>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>Science and Technology Planning Project of Guangdong</institution>
</funding-source>
<award-id>2016A030303066</award-id>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2020</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Background</title>
<p id="Par42">Maturity-onset diabetes of the young (MODY) is a monogenic form of non-autoimmune diabetes mellitus that usually first presents in adolescence or young adulthood, accounting for up to 2% of diabetes in people ages 20 and younger in the United States [<xref ref-type="bibr" rid="CR1">1</xref>]. Depending on the clinical and genetic heterogeneity, 14 subtypes of genetic defects have been proposed to cause MODY [<xref ref-type="bibr" rid="CR2">2</xref>]. For example, mutation in hepatocyte nuclear transcription factor 1 homeobox β (HNF1β) causes MODY5, which accounts for 2 to 6% of MODY [<xref ref-type="bibr" rid="CR3">3</xref>]. On the other hand, approximately 50% of patients with MODY5 are diagnosed with a whole HNF1β gene deletion, which is virtually always part of a Chr17q12 deletion syndrome. Chr17q12 deletion syndrome usually comprises MODY5, and other diseases (i.e., cystic renal disease, pancreatic atrophy, female genital tract abnormalities, and variable cognitive involvement) [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. MODY11 is caused by Ala71Thr mutation in the B lymphocyte kinase (BLK) gene with attenuated BLK activity [<xref ref-type="bibr" rid="CR6">6</xref>]. BLK is expressed in β-cells and enhances insulin synthesis and secretion in response to glucose.</p>
<p id="Par43">Up to now, there is only one case with duodenal atresia reported to be associated with a 17q12 microdeletion [<xref ref-type="bibr" rid="CR7">7</xref>]. Here, we report a MODY patient, with Chr17q12 microdeletion and BLK gene c.211G &gt; A mutation, who had surgery at 5 days after birth for the duodenal atresia. The patient presented bilateral renal cyst without other illnesses or health problems.</p>
</sec>
<sec id="Sec2">
<title>Case presentation</title>
<p id="Par44">The patient was born after a healthy gestation in the Guangdong Province of China and received surgery at 5 days after birth for intestine obstruction caused by the duodenal atresia. The patient’s parents were nonconsanguineous and healthy without a family history of genetic disorders, congenital malformations, diabetes, and psychiatric disease. The patient was diagnosed with diabetes in a medical checkup at the age of 27 years in 2011. Since then, the patient has been receiving insulin treatment and had two pregnancies. During her first pregnancy in 2015, the patient was found with the fetal renal dysplasia and 17q12 deletion (34,822,465-36,283,612) through by B-mode ultrasound and umbilical cord blood gene test, resulting in an induced abortion. Consequently, the patient carried a successful pregnancy and had a healthy daughter in 2017.</p>
<p id="Par45">In March 2018, the patient was re-hospitalized due to poor glycemic control and hyperketonemia. Anthropometric measurements showed the patient had a body weight of 52 kg (average body weight of a Chinese female is 57.3 kg), a height of 162 cm (average height of a Chinese female is 155.8 cm), and a body mass index (BMI) of 19.81 kg/m<sup>2</sup> (normal rang 18.5–23.9 kg/m<sup>2</sup>). Other physical examination results were likewise unremarkable. Mild elevated liver enzymes were discovered (aspartate aminotransferase 47 IU/L, alanine aminotransferase 52 IU/L, lactose dehydrogenase 518 IU/L, alkaline phosphatase 152 IU/L and γ-glutamyl transferase 54 IU/L), while renal function was normal (blood urea nitrogen 6.07 mmol/L, creatinine 61.1 μmol/L, negative for urinary protein). Plasma glucose was 16.74 mmol/L, HbA1c was 12.2%, and blood ketone was 2.8 mmol/L. Analysis of β-cell function markers, including fasting insulin (&lt; 0.2 mIU/L), fasting C-peptide (0.02 μg/L), postprandial-2 h insulin (&lt; 0.2 mIU/L), and postprandial-2 h C-peptide (0.03 μg/L) suggested a severe loss of insulin secreting capacity (electrochemiluminescence immunoassay was used for insulin and C-peptide concentration). The patient was treated with insulin aspart in continuous insulin infusion (20/U insulin for basal/pre-meal bolus doses). Lab examination results showed negative anti-islet autoantibodies (GADA, IA-2, ICA, and IAA) in the patient’s blood using ELISA (GADA), radiobinding assay (IA-2), and radioimmunoassay (ICA and IAA), respectively. Echocardiography and plain X-rays analysis showed normal results. B-mode ultrasound showed a bilateral renal cyst, and cardiac color doppler ultrasound displayed a slightly tricuspid regurgitation.</p>
<p id="Par46">To pinpoint the causative mutations in the patient, we used the cytoscan high-density array to identify microduplications or microdeletions, and used whole-exome sequencing to detect the mutations in genes. In brief, the cytoscan 750 K Array (Affymetrix Inc., Santa Clara, CA) was used for chromosomal microarray, containing 550,000 nonpolymorphic probes and 200,436 single nucleotide polymorphic probes. The copy number variation was analyzed using the Affymetrix Chromosome Analysis Suite software (Version 3.0) and interpreted with the aid of UCSC genome browser (<ext-link ext-link-type="uri" xlink:href="http://gemome.ucsc.edu">http://gemome.ucsc.edu</ext-link>). The exon coding regions of ABCC8, AKT2, BLK, CEL, EIF2AK3, GCK, GLIS3, GLUD1, HADH, HNF1A, HNF1B, HNF4A, INS, INSR, KCNJ11, KLF11, MAPK8IP1, NEUROD1, PAX4, PDX1, PLAGL1, PTF1A, RFX6, SLC19A2, SLC2A2, UCP2, and ZFP57 were directly sequenced to discover possible gene mutations. The analysis results showed a 1.58-Mb region (34,822,465-36,404,104) of hemizygous loss in Chr17q12 (Fig. <xref ref-type="fig" rid="Fig1">1</xref>) and BLK gene p.Ala71Thr (c.211G &gt; A) mutation. The patient showed diabetes and renal cysts. Nevertheless, no other illnesses or health problems were found. To elucidate the various clinical presentations and characteristics of Chr17 deletion, we compared the clinical manifestations in our proband and previously reported patients with a similar deletion region (34,437.475-36,424,950) in Chr17q12 [<xref ref-type="bibr" rid="CR7">7</xref>–<xref ref-type="bibr" rid="CR15">15</xref>] (Fig. <xref ref-type="fig" rid="Fig2">2</xref>, Table <xref ref-type="table" rid="Tab1">1</xref>). As shown in Table <xref ref-type="table" rid="Tab1">1</xref>, individuals with similar gene deletions could manifest various presentations and disorders (such as diabetes, renal cysts, liver and pancreas malformations, and intellectual disability). Even between parents and children without differences in the deletion region, the significant variance in clinical phenotypes is presented [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. Likewise, the severity of renal and pancreatic defects varied between monozygotic twins with MODY5 due to Chr17q12 deletion [<xref ref-type="bibr" rid="CR8">8</xref>].
<fig id="Fig1"><label>Fig. 1</label><caption><p>Molecular karyotyping revealed a deletion of approximately 1.58-Mb in Chr17q12 in patients. <bold>a</bold> Chromosome ideogram. The deletion region is highlighted in red. <bold>b</bold> Cytoscan high-density array identified a 1.58-Mb region (34,822,465-36,404,104) of hemizygous loss. <bold>c</bold> Magnification of the hemizygous loss region. <bold>d</bold> Genes located in the 1.58-Mb hemizygous loss region</p></caption><graphic id="MO1" xlink:href="12881_2020_954_Fig1_HTML"></graphic></fig>
<fig id="Fig2"><label>Fig. 2</label><caption><p>Comparison of deleted regions of Chr17q12. All genomic coordinates were converted to GRCh37/hg19 for comparison</p></caption><graphic id="MO2" xlink:href="12881_2020_954_Fig2_HTML"></graphic></fig>
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Comparisons of clinical manifestations in our proband and previously reported patients with a similar phenotype or deletion region in Chr17q12</p></caption><table frame="hsides" rules="groups"><thead><tr><th></th><th>Our proband</th><th>Roehlen et al. (2018) [<xref ref-type="bibr" rid="CR15">15</xref>]</th><th>Iwasaki et al. (2016) [<xref ref-type="bibr" rid="CR9">9</xref>]</th><th>Goumy et al. (2015) [<xref ref-type="bibr" rid="CR14">14</xref>]</th><th>Quintero-Rivera et al. (2014) [<xref ref-type="bibr" rid="CR7">7</xref>]</th><th>Hinkes et al. (2012) [<xref ref-type="bibr" rid="CR12">12</xref>]</th><th>George et al. (2012) [<xref ref-type="bibr" rid="CR11">11</xref>]</th><th>Dixit et al. (2012) [<xref ref-type="bibr" rid="CR10">10</xref>]</th><th>Moreno-De-Luca et al. (2010) [<xref ref-type="bibr" rid="CR13">13</xref>]</th></tr></thead><tbody><tr><td>Diabetes mellitus</td><td>+</td><td>2/2</td><td>+</td><td>NR</td><td>–</td><td>+</td><td>0/2</td><td>0/3</td><td>1/9</td></tr><tr><td>Renal cysts</td><td>+</td><td>2/2</td><td>+</td><td>+</td><td>+</td><td>+</td><td>1/2</td><td>3/3</td><td>+</td></tr><tr><td>Pancreas abnormalities</td><td>–</td><td>2/2</td><td>+</td><td>NR</td><td>–</td><td>NR</td><td>NR</td><td>0/3</td><td>NR</td></tr><tr><td>Liver abnormalities</td><td>+</td><td>2/2</td><td>+</td><td>+</td><td>+</td><td>NR</td><td>NR</td><td>1/3</td><td>NR</td></tr><tr><td>Facial dysmorphism</td><td>–</td><td>1/2</td><td>NR</td><td>+</td><td>+</td><td>NR</td><td>NR</td><td>2/3</td><td>9/9</td></tr><tr><td>Joint laxity</td><td>–</td><td>NR</td><td>NR</td><td>NR</td><td>+</td><td>+</td><td>NR</td><td>0/3</td><td>NR</td></tr><tr><td>Short stature or failure to thrive</td><td>–</td><td>NR</td><td>NR</td><td>–</td><td>–</td><td>NR</td><td>0/2</td><td>1/3</td><td>1/9</td></tr><tr><td>Autism spectrum disorder</td><td>–</td><td>NR</td><td>NR</td><td>–</td><td>NR</td><td>–</td><td>0/2</td><td>1/3</td><td>6/9</td></tr><tr><td>Intellectual impairment</td><td>–</td><td>2/2</td><td>NR</td><td>–</td><td>NR</td><td>–</td><td>2/2</td><td>3/3</td><td>8/9</td></tr><tr><td>Aggression</td><td>–</td><td>NR</td><td>NR</td><td></td><td>NR</td><td>–</td><td>NR</td><td>NR</td><td>2/9</td></tr><tr><td>Anxiety/disruptive behavior</td><td>–</td><td>NR</td><td>NR</td><td>–</td><td>NR</td><td>–</td><td>1/2</td><td>NR</td><td>5/9</td></tr><tr><td>Hyperactivity</td><td>–</td><td>NR</td><td>NR</td><td>NR</td><td>–</td><td>–</td><td>1/2</td><td>NR</td><td>2/9</td></tr><tr><td>Gastrointestinal abnormalities</td><td>DA</td><td>NR</td><td>NR</td><td>GERD</td><td>DA</td><td>NR</td><td>NR</td><td>NR</td><td>GERD (2/9), FC (2/9)</td></tr></tbody></table><table-wrap-foot><p>+: feature is present, −: feature is absent, <italic>NR</italic> Not reported, <italic>DA</italic> Duodenal atresia, <italic>GERD</italic> Gastroesophageal reflux disease, <italic>FC</italic> Frequent constipation</p></table-wrap-foot></table-wrap></p>
</sec>
<sec id="Sec3">
<title>Discussion and conclusions</title>
<p id="Par47">It has been reported that the incidence of MODY5 is up to 50% [<xref ref-type="bibr" rid="CR16">16</xref>] or 82% in Chr17q12 deletion [<xref ref-type="bibr" rid="CR17">17</xref>]. The renal cystic dysplasia and other structural renal anomalies are the most commonly reported manifestation of the Chr17q12 deletion [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. The whole gene deletion and mutations in the coding region or splice sites of HNF1B cause MODY5 (2 to 6% of MODY diagnoses) that is typically characterized by additional HNF1B-related kidney disease, pancreatic hypoplasia, genital tract malformations, abnormal liver function and early-onset gout [<xref ref-type="bibr" rid="CR3">3</xref>]. It is known that the minimum size for the Chr17q12 deletion is 1.4 Mb DNA sequence in the approximate position of chr17: 34,815,072 - 36,192,492 [<xref ref-type="bibr" rid="CR16">16</xref>]. Our patient’s deletion is 1.58-Mb DNA sequence at the position of chr17: 34,822,465-36,404,104. Notably, our patient diagnosed as MODY5 with bilateral renal cysts has no other severe abnormal phenotypes, while some patients with similar deletion region of chr17 were reported to have the short stature, speech delay and dyspraxia, psychopathology, or autistic traits (Table <xref ref-type="table" rid="Tab1">1</xref>). Among previously studies, three studies reported the gastroesophageal reflux disease in individuals with chr17q12 deletion [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR18">18</xref>], and only one reported the duodenal atresia in the individual with chr17q12 deletion [<xref ref-type="bibr" rid="CR7">7</xref>]. Interestingly, duodenal atresia has been reported in one patient with 17q12 duplication [<xref ref-type="bibr" rid="CR18">18</xref>]. Therefore, it is strongly suggested that genetic defects alone are not sufficient to result in the clinical features associated with the Chr17q12 deletion.</p>
<p id="Par48">In our patient, BLK Ala71Thr mutation was detected. In 2004, Kim et al. firstly reported the MODY was associated with Chr8p23 [<xref ref-type="bibr" rid="CR19">19</xref>]. Borowiec et al. showed the BLK Ala71Thr mutation was responsible for MODY11 by resequencing genomic sequence at 8p23 in 6 MODY families, and revealed the mutation altered the BLK expression and affected MIN6 B-cells activity [<xref ref-type="bibr" rid="CR6">6</xref>]. However, Bonnefond et al. demonstrated a nominal association between this variant and increased type 2 diabetes risk and no mutation in BLK in 64 unelucidated MODY samples [<xref ref-type="bibr" rid="CR20">20</xref>]. The genome databases also show the frequency of BLK p.Ala71Thr (c.211G &gt; A) mutation is very low, only 0.01193 from the Genome Aggregation Database (gnomAD), 0.01171 from Exome Aggregation Consortium (ExAC), and 0.01238 from Global Minor Allele Frequency (GMAF). It suggests that the BLK variant is a benign or a pathological factor combined with other diabetic risk factors. In our case, the patient had a severe loss of insulin secretion capacity with BLK mutation and Chr17q12 deletion, but it was still difficult to evaluate the effect of BLK mutation on diabetes. According to the previously reported data, the BLK variant as a pathology of MODY still requires further validation.</p>
<p id="Par49">The previous studies revealed the various clinical manifestations of Chr17q12 deletion. Here, we reported a woman who developed MODY5 with the Chr17q12 deletion and duodenal atresia. Our reported new phenomena further demonstrated the clinical variability of MODY5.</p>
</sec>
</body>
<back>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>ABCC8</term>
<def>
<p id="Par4">Adenosine triphosphate (ATP)-binding cassette; sub-family C (CFTR/MRP) member 8</p>
</def>
</def-item>
<def-item>
<term>AKT2</term>
<def>
<p id="Par5">Protein kinase B beta</p>
</def>
</def-item>
<def-item>
<term>BLK</term>
<def>
<p id="Par6">Heterozygous mutation in B lymphocyte kinase</p>
</def>
</def-item>
<def-item>
<term>BMI</term>
<def>
<p id="Par7">Body mass index</p>
</def>
</def-item>
<def-item>
<term>CEL</term>
<def>
<p id="Par8">Carboxyl ester lipase</p>
</def>
</def-item>
<def-item>
<term>EIF2AK3</term>
<def>
<p id="Par9">Eukaryotic translation initiation factor 2-alpha kinase 3</p>
</def>
</def-item>
<def-item>
<term>ELISA</term>
<def>
<p id="Par10">Enzyme-linked immunosorbent assay</p>
</def>
</def-item>
<def-item>
<term>ExAC</term>
<def>
<p id="Par11">Exome Aggregation Consortium</p>
</def>
</def-item>
<def-item>
<term>GADA</term>
<def>
<p id="Par12">Glutamic acid decarboxylase 65 autoantibody</p>
</def>
</def-item>
<def-item>
<term>GCK</term>
<def>
<p id="Par13">Glucokinase (GCK)</p>
</def>
</def-item>
<def-item>
<term>GLIS3</term>
<def>
<p id="Par14">GLI-similar 3</p>
</def>
</def-item>
<def-item>
<term>GLUD1</term>
<def>
<p id="Par15">Glutamate dehydrogenase 1 gene</p>
</def>
</def-item>
<def-item>
<term>GMAF</term>
<def>
<p id="Par16">Global Minor Allele Frequency</p>
</def>
</def-item>
<def-item>
<term>gnomAD</term>
<def>
<p id="Par17">Genome Aggregation Database</p>
</def>
</def-item>
<def-item>
<term>HADH</term>
<def>
<p id="Par18">Hydroxy-acyl-CoA dehydrogenase</p>
</def>
</def-item>
<def-item>
<term>HNF1A</term>
<def>
<p id="Par19">Hepatocyte nuclear factor 1A</p>
</def>
</def-item>
<def-item>
<term>HNF1B</term>
<def>
<p id="Par20">Hepatocyte nuclear factor 1B</p>
</def>
</def-item>
<def-item>
<term>HNF1β</term>
<def>
<p id="Par21">Hepatocyte nuclear factor 1 homeobox β gene</p>
</def>
</def-item>
<def-item>
<term>HNF4A</term>
<def>
<p id="Par22">Hepatocyte nuclear factor 4A</p>
</def>
</def-item>
<def-item>
<term>IA2A</term>
<def>
<p id="Par23">Insulinoma-associated protein 2 autoantibody</p>
</def>
</def-item>
<def-item>
<term>IAA</term>
<def>
<p id="Par24">Insulin autoantibody</p>
</def>
</def-item>
<def-item>
<term>ICA</term>
<def>
<p id="Par25">Islet cell autoantibodies</p>
</def>
</def-item>
<def-item>
<term>INS</term>
<def>
<p id="Par26">Insulin</p>
</def>
</def-item>
<def-item>
<term>INSR</term>
<def>
<p id="Par27">Insulin receptor</p>
</def>
</def-item>
<def-item>
<term>KCNJ11</term>
<def>
<p id="Par28">Potassium channel inwardly rectifying subfamily; member 11</p>
</def>
</def-item>
<def-item>
<term>KLF11</term>
<def>
<p id="Par29">Kruppel-like factor 11</p>
</def>
</def-item>
<def-item>
<term>MAPK8IP1</term>
<def>
<p id="Par30">Mitogen-activated protein kinase 8 interacting protein 1</p>
</def>
</def-item>
<def-item>
<term>MODY</term>
<def>
<p id="Par31">Maturity-onset diabetes of the young</p>
</def>
</def-item>
<def-item>
<term>NEUROD1</term>
<def>
<p id="Par32">Neurogenic differentiation 1</p>
</def>
</def-item>
<def-item>
<term>PAX4</term>
<def>
<p id="Par33">Paired-box-containing gene 4</p>
</def>
</def-item>
<def-item>
<term>PDX1</term>
<def>
<p id="Par34">Pancreatic and duodenal homeobox 1</p>
</def>
</def-item>
<def-item>
<term>PLAGL1</term>
<def>
<p id="Par35">Pleiomorphic adenoma gene 1</p>
</def>
</def-item>
<def-item>
<term>PTF1A</term>
<def>
<p id="Par36">Pancreas-specific transcription factor 1A</p>
</def>
</def-item>
<def-item>
<term>RFX6</term>
<def>
<p id="Par37">Regulatory factor X 6</p>
</def>
</def-item>
<def-item>
<term>SLC19A2</term>
<def>
<p id="Par38">Solute carrier family 19 member 2</p>
</def>
</def-item>
<def-item>
<term>SLC2A2</term>
<def>
<p id="Par39">Solute carrier family 2 member 2</p>
</def>
</def-item>
<def-item>
<term>UCP2</term>
<def>
<p id="Par40">Uncoupling Protein 2</p>
</def>
</def-item>
<def-item>
<term>ZFP57</term>
<def>
<p id="Par41">Zinc finger protein 57</p>
</def>
</def-item>
</def-list>
</glossary>
<fn-group>
<fn>
<p>
<bold>Publisher’s Note</bold>
</p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</fn>
</fn-group>
<ack>
<p>The authors sincerely thank the patient’s collaboration.</p>
</ack>
<notes notes-type="author-contribution">
<title>Authors’ contributions</title>
<p>TD and NZ collected the clinical information and the literature data, and drafted the manuscript. XW and PZ coordinated the gene evaluation and study. WL critically reviewed and edited the manuscript. All authors approved the submitted version of the manuscript.</p>
</notes>
<notes notes-type="funding-information">
<title>Funding</title>
<p>This work was supported by the Natural Science Foundation of Guangdong Province of China (No. 2014A030313488), the Science and Technology Planning Project of Guangzhou City of China (No. 201607010036), the Science and Technology Planning Project of Guangdong Province of China (No. 2016A030303066). These funds sponsored the genetic test and analysis, and the other expense we conducted for this case. The funding bodies played no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.</p>
</notes>
<notes notes-type="data-availability">
<title>Availability of data and materials</title>
<p>The data used and/or analyzed in the present report were deposited in the Sequence Read Archive (SRA) database. The data are accessible via the SRA accession: PRJNA600784; or via the links: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/sra/PRJNA600784;">https://www.ncbi.nlm.nih.gov/sra/PRJNA600784;</ext-link>
<ext-link ext-link-type="uri" xlink:href="https://trace.ncbi.nlm.nih.gov/Traces/sra/?run=SRR10875069">https://trace.ncbi.nlm.nih.gov/Traces/sra/?run=SRR10875069</ext-link>.</p>
</notes>
<notes>
<title>Ethics approval and consent to participate</title>
<p id="Par50">This study was approved by the academic ethics review boards of the Second Affiliated Hospital of Guangzhou Medical University. The authors obtained written consent from the patient for all genetic analysis.</p>
</notes>
<notes>
<title>Consent for publication</title>
<p id="Par51">All authors declared the patient has signed written informed consent for publication of clinical, radiological, and biological data.</p>
</notes>
<notes notes-type="COI-statement">
<title>Competing interests</title>
<p id="Par52">The authors declare that they have no competing interests.</p>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pihoker</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Gilliam</surname>
<given-names>LK</given-names>
</name>
<name>
<surname>Ellard</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dabelea</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Dolan</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Greenbaum</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Imperatore</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Lawrence</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Marcovina</surname>
<given-names>SM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prevalence, characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in HNF1A, HNF4A, and glucokinase: results from the SEARCH for diabetes in youth</article-title>
<source/>J Clin Endocrinol Metab
          <year>2013</year>
<volume>98</volume>
<issue>10</issue>
<fpage>4055</fpage>
<lpage>4062</lpage>
<pub-id pub-id-type="doi">10.1210/jc.2013-1279</pub-id>
<pub-id pub-id-type="pmid">23771925</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>SH</given-names>
</name>
</person-group>
<article-title>Maturity-onset diabetes of the young: what do clinicians need to know?</article-title>
<source/>Diabetes Metab J
          <year>2015</year>
<volume>39</volume>
<issue>6</issue>
<fpage>468</fpage>
<lpage>477</lpage>
<pub-id pub-id-type="doi">10.4093/dmj.2015.39.6.468</pub-id>
<pub-id pub-id-type="pmid">26706916</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clissold</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Hamilton</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Hattersley</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Ellard</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bingham</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>HNF1B-associated renal and extra-renal disease-an expanding clinical spectrum</article-title>
<source/>Nat Rev Nephrol
          <year>2015</year>
<volume>11</volume>
<issue>2</issue>
<fpage>102</fpage>
<lpage>112</lpage>
<pub-id pub-id-type="doi">10.1038/nrneph.2014.232</pub-id>
<pub-id pub-id-type="pmid">25536396</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Loirat</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bellanne-Chantelot</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Husson</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Deschenes</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Guigonis</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Chabane</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Autism in three patients with cystic or hyperechogenic kidneys and chromosome 17q12 deletion</article-title>
<source/>Nephrol Dial Transplant
          <year>2010</year>
<volume>25</volume>
<issue>10</issue>
<fpage>3430</fpage>
<lpage>3433</lpage>
<pub-id pub-id-type="doi">10.1093/ndt/gfq380</pub-id>
<pub-id pub-id-type="pmid">20587423</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nagamani</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Erez</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Roeder</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Cox</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Karaviti</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Pearson</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Sahoo</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Clinical spectrum associated with recurrent genomic rearrangements in chromosome 17q12</article-title>
<source/>Eur J Hum Genet
          <year>2010</year>
<volume>18</volume>
<issue>3</issue>
<fpage>278</fpage>
<lpage>284</lpage>
<pub-id pub-id-type="doi">10.1038/ejhg.2009.174</pub-id>
<pub-id pub-id-type="pmid">19844256</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Borowiec</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Liew</surname>
<given-names>CW</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Boonyasrisawat</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mlynarski</surname>
<given-names>WM</given-names>
</name>
<name>
<surname>El Khattabi</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Marselli</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Rich</surname>
<given-names>SS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutations at the BLK locus linked to maturity onset diabetes of the young and beta-cell dysfunction</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2009</year>
<volume>106</volume>
<issue>34</issue>
<fpage>14460</fpage>
<lpage>14465</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0906474106</pub-id>
<pub-id pub-id-type="pmid">19667185</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quintero-Rivera</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Woo</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Bomberg</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Wallace</surname>
<given-names>WD</given-names>
</name>
<name>
<surname>Peredo</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Dipple</surname>
<given-names>KM</given-names>
</name>
</person-group>
<article-title>Duodenal atresia in 17q12 microdeletion including HNF1B: a new associated malformation in this syndrome</article-title>
<source/>Am J Med Genet A
          <year>2014</year>
<volume>164A</volume>
<issue>12</issue>
<fpage>3076</fpage>
<lpage>3082</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.36767</pub-id>
<pub-id pub-id-type="pmid">25256560</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ohara</surname>
<given-names>Yasuko</given-names>
</name>
<name>
<surname>Okada</surname>
<given-names>Yuko</given-names>
</name>
<name>
<surname>Yamada</surname>
<given-names>Tomoko</given-names>
</name>
<name>
<surname>Sugawara</surname>
<given-names>Kenji</given-names>
</name>
<name>
<surname>Kanatani</surname>
<given-names>Masayuki</given-names>
</name>
<name>
<surname>Fukuoka</surname>
<given-names>Hidenori</given-names>
</name>
<name>
<surname>Hirota</surname>
<given-names>Yushi</given-names>
</name>
<name>
<surname>Maeda</surname>
<given-names>Takaki</given-names>
</name>
<name>
<surname>Morisada</surname>
<given-names>Naoya</given-names>
</name>
<name>
<surname>Iijima</surname>
<given-names>Kazumoto</given-names>
</name>
<name>
<surname>Ogawa</surname>
<given-names>Wataru</given-names>
</name>
</person-group>
<article-title>Phenotypic differences and similarities of monozygotic twins with maturity-onset diabetes of the young type 5</article-title>
<source/>Journal of Diabetes Investigation
          <year>2019</year>
<volume>10</volume>
<issue>4</issue>
<fpage>1112</fpage>
<lpage>1115</lpage>
<pub-id pub-id-type="doi">10.1111/jdi.13004</pub-id>
<pub-id pub-id-type="pmid">30637974</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iwasaki</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Tsurumi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Asai</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Shimuzu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ogata</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Takizawa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ide</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Saito</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Pancreatic developmental defect evaluated by celiac artery angiography in a patient with MODY5</article-title>
<source/>Hum Genome Var
          <year>2016</year>
<volume>3</volume>
<fpage>16022</fpage>
<pub-id pub-id-type="doi">10.1038/hgv.2016.22</pub-id>
<pub-id pub-id-type="pmid">27468355</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dixit</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Harrison</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Jarvis</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hulton</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Yates</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Silcock</surname>
<given-names>L</given-names>
</name>
<name>
<surname>McMullan</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Suri</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>17q12 microdeletion syndrome: three patients illustrating the phenotypic spectrum</article-title>
<source/>Am J Med Genet A
          <year>2012</year>
<volume>158A</volume>
<issue>9</issue>
<fpage>2317</fpage>
<lpage>2321</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.35520</pub-id>
<pub-id pub-id-type="pmid">22887843</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>George</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Love</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Hayes</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Tsang</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Recurrent transmission of a 17q12 microdeletion and a variable clinical Spectrum</article-title>
<source/>Mol Syndromol
          <year>2012</year>
<volume>2</volume>
<issue>2</issue>
<fpage>72</fpage>
<lpage>75</lpage>
<pub-id pub-id-type="pmid">22511894</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hinkes</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Hilgers</surname>
<given-names>KF</given-names>
</name>
<name>
<surname>Bolz</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Goppelt-Struebe</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Amann</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Nagl</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bergmann</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Rascher</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Eckardt</surname>
<given-names>KU</given-names>
</name>
<name>
<surname>Jacobi</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>A complex microdeletion 17q12 phenotype in a patient with recurrent de novo membranous nephropathy</article-title>
<source/>BMC Nephrol
          <year>2012</year>
<volume>13</volume>
<fpage>27</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2369-13-27</pub-id>
<pub-id pub-id-type="pmid">22583611</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moreno-De-Luca</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Consortium</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mulle</surname>
<given-names>JG</given-names>
</name>
<collab>Simons Simplex Collection Genetics C</collab>
<name>
<surname>Kaminsky</surname>
<given-names>EB</given-names>
</name>
<name>
<surname>Sanders</surname>
<given-names>SJ</given-names>
</name>
<collab>GeneStar</collab>
<name>
<surname>Myers</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Adam</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Pakula</surname>
<given-names>AT</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Deletion 17q12 is a recurrent copy number variant that confers high risk of autism and schizophrenia</article-title>
<source/>Am J Hum Genet
          <year>2010</year>
<volume>87</volume>
<issue>5</issue>
<fpage>618</fpage>
<lpage>630</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2010.10.004</pub-id>
<pub-id pub-id-type="pmid">21055719</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goumy</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Laffargue</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Eymard-Pierre</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Kemeny</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gay-Bellile</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gouas</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gallot</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Francannet</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Tchirkov</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pebrel-Richard</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Congenital diaphragmatic hernia may be associated with 17q12 microdeletion syndrome</article-title>
<source/>Am J Med Genet A
          <year>2015</year>
<volume>167A</volume>
<issue>1</issue>
<fpage>250</fpage>
<lpage>253</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.36840</pub-id>
<pub-id pub-id-type="pmid">25425496</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roehlen</surname>
<given-names>Natascha</given-names>
</name>
<name>
<surname>Hilger</surname>
<given-names>Hanna</given-names>
</name>
<name>
<surname>Stock</surname>
<given-names>Friedrich</given-names>
</name>
<name>
<surname>Gläser</surname>
<given-names>Birgitta</given-names>
</name>
<name>
<surname>Guhl</surname>
<given-names>Johannes</given-names>
</name>
<name>
<surname>Schmitt-Graeff</surname>
<given-names>Annette</given-names>
</name>
<name>
<surname>Seufert</surname>
<given-names>Jochen</given-names>
</name>
<name>
<surname>Laubner</surname>
<given-names>Katharina</given-names>
</name>
</person-group>
<article-title>17q12 Deletion Syndrome as a Rare Cause for Diabetes Mellitus Type MODY5</article-title>
<source/>The Journal of Clinical Endocrinology &amp; Metabolism
          <year>2018</year>
<volume>103</volume>
<issue>10</issue>
<fpage>3601</fpage>
<lpage>3610</lpage>
<pub-id pub-id-type="doi">10.1210/jc.2018-00955</pub-id>
<pub-id pub-id-type="pmid">30032214</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<mixed-citation publication-type="other">Mitchel MW, Moreno-De-Luca D, Myers SM, Finucane B, Ledbetter DH, Martin CL. 17q12 Recurrent Deletion Syndrome. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019.</mixed-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dubois-Laforgue</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Cornu</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Saint-Martin</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Coste</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bellanne-Chantelot</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Timsit</surname>
<given-names>J</given-names>
</name>
<collab>Monogenic Diabetes Study Group of the Societe Francophone du D</collab>
</person-group>
<article-title>Diabetes, associated clinical spectrum, long-term prognosis, and genotype/phenotype correlations in 201 adult patients with hepatocyte nuclear factor 1B (HNF1B) molecular defects</article-title>
<source/>Diabetes Care
          <year>2017</year>
<volume>40</volume>
<issue>11</issue>
<fpage>1436</fpage>
<lpage>1443</lpage>
<pub-id pub-id-type="doi">10.2337/dc16-2462</pub-id>
<pub-id pub-id-type="pmid">28420700</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rasmussen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Vestergaard</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Graakjaer</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Petkov</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Bache</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Fagerberg</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kibaek</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Svaneby</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Petersen</surname>
<given-names>OB</given-names>
</name>
<name>
<surname>Brasch-Andersen</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>17q12 deletion and duplication syndrome in Denmark-A clinical cohort of 38 patients and review of the literature</article-title>
<source/>Am J Med Genet A
          <year>2016</year>
<volume>170</volume>
<issue>11</issue>
<fpage>2934</fpage>
<lpage>2942</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.37848</pub-id>
<pub-id pub-id-type="pmid">27409573</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Weremowicz</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ercolino</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Powers</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Mlynarski</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Bashan</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Warram</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Mychaleckyj</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Rich</surname>
<given-names>SS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Identification of a locus for maturity-onset diabetes of the young on chromosome 8p23</article-title>
<source/>Diabetes
          <year>2004</year>
<volume>53</volume>
<issue>5</issue>
<fpage>1375</fpage>
<lpage>1384</lpage>
<pub-id pub-id-type="doi">10.2337/diabetes.53.5.1375</pub-id>
<pub-id pub-id-type="pmid">15111509</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bonnefond</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Yengo</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Philippe</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Dechaume</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ezzidi</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Vaillant</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Gjesing</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Andersson</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Czernichow</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hercberg</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Reassessment of the putative role of BLK-p.A71T loss-of-function mutation in MODY and type 2 diabetes</article-title>
<source/>Diabetologia
          <year>2013</year>
<volume>56</volume>
<issue>3</issue>
<fpage>492</fpage>
<lpage>496</lpage>
<pub-id pub-id-type="doi">10.1007/s00125-012-2794-8</pub-id>
<pub-id pub-id-type="pmid">23224494</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>